|Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1|
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
|International network of cancer genome projects|
International Cancer Genome Consortium
Nature 464 (7291), 993, 2010
|Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening|
EKO Ng, WWS Chong, H Jin, EKY Lam, VY Shin, J Yu, TCW Poon, ...
Gut 58 (10), 1375-1381, 2009
|Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years|
VWS Wong, GLH Wong, PCL Choi, AWH Chan, MKP Li, HY Chan, ...
Gut 59 (7), 969-974, 2010
|Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer|
WP Tsang, EKO Ng, SSM Ng, H Jin, J Yu, JJY Sung, TT Kwok
Carcinogenesis 31 (3), 350-358, 2010
|Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer|
J Yu, Q Feng, SH Wong, D Zhang, Q yi Liang, Y Qin, L Tang, H Zhao, ...
Gut 66 (1), 70-78, 2017
|Gut mucosal microbiome across stages of colorectal carcinogenesis|
G Nakatsu, X Li, H Zhou, J Sheng, SH Wong, WKK Wu, SC Ng, H Tsoi, ...
Nature communications 6 (1), 1-9, 2015
|A catalog of the mouse gut metagenome|
L Xiao, Q Feng, S Liang, SB Sonne, Z Xia, X Qiu, X Li, H Long, J Zhang, ...
Nature biotechnology 33 (10), 1103-1108, 2015
|MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer|
EKO Ng, WP Tsang, SSM Ng, HC Jin, J Yu, JJ Li, C Röcken, MPA Ebert, ...
British journal of cancer 101 (4), 699-706, 2009
|MicroRNA dysregulation in gastric cancer: a new player enters the game|
WKK Wu, CW Lee, CH Cho, D Fan, K Wu, J Yu, JJY Sung
Oncogene 29 (43), 5761-5771, 2010
|Improved survival of gastric cancer with tumour Epstein–Barr virus positivity: an international pooled analysis|
MC Camargo, WH Kim, AM Chiaravalli, KM Kim, AH Corvalan, K Matsuo, ...
Gut 63 (2), 236-243, 2014
|Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease|
VWS Wong, GLH Wong, GWK Yip, AOS Lo, J Limquiaco, WCW Chu, ...
Gut 60 (12), 1721-1727, 2011
|Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps|
CW Wu, SSM Ng, YJ Dong, SC Ng, WW Leung, CW Lee, YN Wong, ...
Gut 61 (5), 739-745, 2012
|Gavage of fecal samples from patients with colorectal cancer promotes intestinal carcinogenesis in germ-free and conventional mice|
SH Wong, L Zhao, X Zhang, G Nakatsu, J Han, W Xu, X Xiao, TNY Kwong, ...
Gastroenterology 153 (6), 1621-1633. e6, 2017
|Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis–a longitudinal study|
VWS Wong, CH Tse, TTY Lam, GLH Wong, AML Chim, WCW Chu, ...
PloS one 8 (4), e62885, 2013
|Animal models of non‐alcoholic fatty liver disease: current perspectives and recent advances|
JKC Lau, X Zhang, J Yu
The Journal of pathology 241 (1), 36-44, 2017
|Mucosal microbiome dysbiosis in gastric carcinogenesis|
OO Coker, Z Dai, Y Nie, G Zhao, L Cao, G Nakatsu, WKK Wu, SH Wong, ...
Gut 67 (6), 1024-1032, 2018
|The autophagic paradox in cancer therapy|
WKK Wu, SB Coffelt, CH Cho, XJ Wang, CW Lee, FKL Chan, J Yu, ...
Oncogene 31 (8), 939-953, 2012
|Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer|
J Yu, WKK Wu, X Li, J He, XX Li, SSM Ng, C Yu, Z Gao, J Yang, M Li, ...
Gut 64 (4), 636-645, 2015
|High serum interleukin‐6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B|
VWS Wong, J Yu, ASL Cheng, GLH Wong, HY Chan, ESH Chu, EKO Ng, ...
International journal of cancer 124 (12), 2766-2770, 2009